---
title: "UTHR.US (UTHR.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/UTHR.US/news.md"
symbol: "UTHR.US"
name: "UTHR.US"
parent: "https://longbridge.com/en/quote/UTHR.US.md"
datetime: "2026-05-19T19:29:14.509Z"
locales:
  - [en](https://longbridge.com/en/quote/UTHR.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/UTHR.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/UTHR.US/news.md)
---

# UTHR.US (UTHR.US) — Related News

### [Quant ratings on Renaissance Technologies' top holdings: UTHR, PLTR, AAPL](https://longbridge.com/en/news/286806751.md)
*2026-05-18T18:23:18.000Z*
> Renaissance Technologies reported a -4.58% return in Q1 2026, slightly better than the S&P 500's -4.63%. Its Q1 holdings

### [United Therapeutics Says Pulmonary Arterial Hypertension Treatment Meets Primary Endpoint in Late-Stage Trial](https://longbridge.com/en/news/286741658.md)
*2026-05-18T08:43:00.000Z*
> United Therapeutics' phase 3 trial of ralinepag for pulmonary arterial hypertension met its primary endpoint, reducing c

### [Baidu, Brady And 3 Stocks To Watch Heading Into Monday](https://longbridge.com/en/news/286723418.md)
*2026-05-18T06:13:00.000Z*
> U.S. stock futures are lower as investors watch Baidu Inc. (BIDU) expected to report earnings of $1.69 per share on $4.6

### [TD Cowen Reaffirms Their Buy Rating on United Therapeutics (UTHR)](https://longbridge.com/en/news/286711472.md)
*2026-05-18T03:55:12.000Z*
> TD Cowen analyst Joseph Thome has reaffirmed a Buy rating on United Therapeutics (UTHR) with a price target of $675.00. 

### [United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026 | UTHR Stock News](https://longbridge.com/en/news/286679932.md)
*2026-05-17T10:15:38.000Z*
> United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026 | UTHR Stock News

### [3 Low Risk Leaders Powering AI, Pulmonary Drugs And Defense](https://longbridge.com/en/news/286654158.md)
*2026-05-16T22:14:33.000Z*
> In a volatile market, investors are turning to low-risk stocks. This article highlights three companies: Citizens Financ

### [United Therapeutics (NASDAQ:UTHR) CFO James Edgemond Sells 10,000 Shares](https://longbridge.com/en/news/286643771.md)
*2026-05-16T11:09:59.000Z*
> CFO James Edgemond of United Therapeutics (NASDAQ:UTHR) sold 10,000 shares at an average price of $574.47, totaling $5,7

### [United Therapeutics Insider Sold Shares Worth $5,744,746, According to a Recent SEC Filing](https://longbridge.com/en/news/286618742.md)
*2026-05-15T21:08:00.000Z*
> James Edgemond, CFO of United Therapeutics, sold 10,000 shares for $5,744,746 on May 14, 2026. Following the SEC Form 4